01—History
Free Cash Flow History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $2.05B
YoY changeLargest recent move+114.3%in FY24Latest −24.7%
02—Ledger
Free Cash Flow, period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2025 | $2.05B | −24.7% | 10-K | |
| FY2024 | $2.72B | +114.3% | 10-K | |
| FY2023 | $1.27B | +11.0% | 10-K | |
| FY2022 | $1.14B | −66.2% | 10-K | |
| FY2021 | $3.38B | −11.1% | 10-K | |
| FY2020 | $3.81B | −42.0% | 10-K | |
| FY2019 | $6.56B | +21.2% | 10-K | |
| FY2018 | $5.42B | +47.1% | 10-K | |
| FY2017 | $3.68B | −7.2% | 10-K | |
| FY2016 | $3.97B | +21.2% | 10-K | |
| FY2015 | $3.28B | +23.4% | 10-K | |
| FY2014 | $2.65B | +26.5% | 10-K | |
| FY2013 | $2.10B | +29.1% | 10-K | |
| FY2012 | $1.63B | +7.0% | 10-K | |
| FY2011 | $1.52B | +4.7% | 10-K | |
| FY2010 | $1.45B | +59.6% | 10-K | |
| FY2009 | $909.3M | −29.3% | 10-K | |
| FY2008 | $1.29B | +75.1% | 10-K | |
| FY2007 | $734.6M | — | 10-K |
03—Questions
What is BIOGEN INC.'s current free cash flow?
BIOGEN INC. (BIIB) annual free cash flow for 2025 was $2.05B, a 24.65% decline from 2024. BIOGEN INC. free cash flow for the quarter ending March 31, 2026 was $594.3M.
What was BIOGEN INC.'s free cash flow in 2024?
BIOGEN INC. annual free cash flow for 2024 was $2.72B, a 114.28% increase from 2023.
What was BIOGEN INC.'s free cash flow in 2023?
BIOGEN INC. annual free cash flow for 2023 was $1.27B, a 11.03% increase from 2022.
What is BIOGEN INC.'s 5-year free cash flow CAGR?
BIOGEN INC. free cash flow grew at a compound annual growth rate (CAGR) of 11.63% from FY2020 to FY2025, going from $3.81B to $2.05B over 5 years.
- Company
- BIOGEN INC.
- Ticker
- BIIB
- Sector
- Healthcare
- Industry
- Biological Products, (No Diagnostic Substances)